Study says Low-dose Aspirin Safe Way to Reduce Colon Cancer Risk

A recent study showed that taking lower dose of aspirin is a safer way to reduce the risk of colon cancer.

British researchers found out that taking a lower dose of aspirin can help reduce number of cases of colon cancers and its cancer death rates.

Colon cancer is the second to the leading cancer form in developed countries, and the findings bring light to their research that aspirin can help a person in preventing the occurrenceof colon cancer.

The findings been published in the Lancet Medical Journal, however the findings are unlikely to settle due to the controversies about aspirin.

In previous studies, it shows that people who take high levels and doses of aspirin can be very effective in preventing the developmentof colon cancer to a person.

However, consumption of this medicine can be very hazardous to most people; it oftentimes caused deadly and serious bleeding in a person’s intestines and stomach.

Another study regarding to a related painkiller medicine, ibuprofen also help reduce the cancer rates of colon cancer, for people who take the medication over a long period of time.

Lead author of the study, Peter Rothwell, from John Radcliffe Hospital in Oxford, together with his team, conducted four large studies of more than 14,000 people. Half of their subjects take low-dose of aspirin intended for treating heart disease.

Eighteen years later, only 2.8 percent of those volunteers developed and acquired colorectal cancer. They have found out that aspirin effectively reduce the risk of this illness by 24 percent, and at the same time it also lowered the risk of a person to die from this kind of disease by almost 35 percent.

These findings can help people who cannot afford expensive diagnosis and treatments for colon cancer, to get an affordable medication to prevent colorectal cancer in the future.

Via : seedol

IV Aspirin Found to Be Safe, Effective in Severe Headache

Intravenous (IV) aspirin appears to be effective and safe in the treatment of patients hospitalized for the management of severe headache, according to research published in the Sept. 21 issue of Neurology.

Mark W. Weatherall, Ph.D., of the National Hospital for Neurology and Neurosurgery in London, and colleagues reviewed the records of 168 severe headache patients who received IV aspirin (lysine acetylsalicylic acid), most of whom had overused and were withdrawing from other pain medications.

The researchers found that, on more than a quarter of the occasions on which IV aspirin was administered, there was at least a three-point decrease on a 10-point visual analog pain scale. There was an overall adverse effect rate of 5.9 percent, with no serious adverse events reported. Two patients discontinued aspirin treatment: one asthma patient who had a decrease in vital capacity and a second patient who became needle phobic. The most common adverse events were nausea and cannula pain, experienced by four and three patients, respectively.

"In summary, IV lysine acetylsalicylic acid (aspirin) is effective and well-tolerated in the management of severe rebound headache in patients undergoing medication withdrawal," the authors write.

Several authors disclosed financial ties to pharmaceutical and/or medical device companies. One author estimates that 5 percent of his practice involves administering IV aspirin to headache patients.

Via : modernmedicine.com